' fill='%23ffffff'%3E%3Cpath d='M283.94,167.31l386.39,516.64L281.5,1104h87.51l340.42-367.76L984.48,1104h297.8L874.15,558.3l361.92-390.99 h-87.51l-313.51,338.7l-253.31-338.7H283.94z M412.63,231.77h136.81l604.13,807.76h-136.81L412.63,231.77z'%3E%3C/path%3E%3C/g%3E%3C/svg%3E%0A){kind=small}
Search result
‘VPAG boost is ultimately about better patient outcomes across Scotland and realising true value’
The Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) must ultimately be about realising true value for the benefit of patients, says NHS Research Scotland (NRS) Last year, it was announced that £100m in public-private investment from pharmaceutical companies would deliver 20 research hubs across the UK as part of the wider £400 million VPAG scheme. Under its accompanying investment programme, Commercial Research Delivery Centres (CRDCs) will...
Scottish Cross-Sector Hub set for second gathering after launch success
The Academy of Medical Sciences Scotland Cross-Sector Hub is inviting attendees to its second event after a successful launch in March The free to attend event, taking place at the COSLA Conference Centre in Edinburgh on Wednesday 4 June, and hosted by NHS Research Scotland (NRS), will place its prime focus on research and innovation in ‘Precision Medicine and Precision Popu...
NHS Research Scotland Primary Care Network Bursary Scheme opens up ‘world of conference opportunities’
Applications are now being invited for a conference bursary which has been made available for a fourth year by the NHS Research Scotland (NRS) Primary Care Network The scheme encourages GP trainees and medical students to apply, allowing recipients to attend a national Primary Care conference and deepen their research knowledge while helping to potentially shape future clinical approaches. Th...
Updated expectations for agreements used by commercial sponsors now published
The Health Research Authority (HRA) has today (Monday 28 April 2025) announced the publication of a new model Commercial Chief Investigator Agreement (mCCIA), and model Confidential Disclosure Agreements (mCDA), both of which are expected to be used without modification Announced in an edition of the organisation’s HRA Now bulletin, the guidance is expected to be of most use to Commercial Spon...
Ninewells Hospital recruits first patient for trial aimed at improving treatment of specific leukaemia
The University of Dundee and NHS Tayside has successfully recruited the first patient in the UK to a clinical trial that aims to improve treatments for a sub-group of patients affected by an aggressive blood cancer Led by Cardiff University, the OPTIMISE-FLT3 study officially opened for recruitment on 19 February, marking what the Co-Chief Investigators have called “a significant step forward” in evaluating new treatment strategies for FLT3-mutu...
New UK clinical trials regulations signed into law — implementation period begins
New rules for running clinical trials in the UK have now been officially been signed into law The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were formally signed by Wes Streeting MP, Secretary of State for Health and Social Care yesterday. Yesterday (10 April 2025) marks the start of a 12-month implementation period before the amended regulations come fully into force on 10 April 2026. The updated regulations will soon be available on th...
Scottish study activity continues to seek answers during Bowel Cancer Awareness Month
Bowel Cancer Awareness Month (1-30 April) is encouraging the sharing of experiences and symptoms — with Scotland’s researchers supporting the drive for treatments through diverse trials More than nine in 10 people survive bowel cancer — the fourth most common type of cancer in the UK — when it is diagnosed at the earliest stage, so education on spotting the signs is vital. While Bowel Cancer UK is encouraging information sharing through t...
Ninewells Hospital is UK’s joint top recruiter for trial aimed at treating life-threatening respiratory condition
The University of Dundee and NHS Tayside has been named the UK’s joint top recruiting site for a trial involving 65 hospitals, exploring dexamethasone treatment in patients with acute respiratory distress syndrome (ARDS) The Glucocorticoids in adults with Acute Respiratory Distress Syndrome (GuARDS) trial being delivered at Ninewells Hospital in Dundee — and led by the local Principal Investigator, Dr Matt Cassey — has recruited 16 participants. Tha...
Neuroprogressive and Dementia Network support helps to identify priorities for inclusive future studies
Results of a pilot project supported by the NHS Research Scotland Neuroprogressive and Dementia Network (NRS NDN) are expected to help shape future studies which address a disparity for people living with dementia and co-existing health conditions. The project, entitled ‘Exploring the Priorities of People with Dementia and Multiple Comorbidities’, saw focus groups...
NHS Research Scotland Trauma and Emergencies portfolio seeking to appoint new Clinical Lead
The Chief Scientist Office (CSO) is looking to appoint a National Research Network Clinical Lead for the NHS Research Scotland (NRS) Trauma and Emergencies portfolio The remit of this role is to support the effective delivery of research projects in the corresponding topic area in the NRS portfolio, including increasing the number of patients enrolled into trials....
